AstraZeneca (NASDAQ:AZN) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, the first patient was dosed by ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Trastuzumab deruxtecan plus pertuzumab showed significant improvement in PFS compared with taxane chemotherapy plus trastuzumab and pertuzumab across patients with HER2-positive metastatic breast ...

New data shed light on the best strategies for managing patients who develop interstitial lung disease while being treated ...

PFE's new drug launches and Seagen acquisition are driving revenue gains despite COVID declines and market headwinds.

I rebuilt my life after breast cancer—finding love, moving states, and embracing joy. Then, everything turned upside down.

ASCO Annual Meeting highlighted key advances in brain cancer and brain metastases for patients affected by the disease.

That being said, we’re here with a list of the 9 best inexpensive stocks to buy right now. We used the Finviz stock screener to compile a list of the top stocks with a forward P/E ratio of 20 or less, ...

AstraZeneca and Daiichi Sankyo are preparing regulatory filings that could make their HER2-directed antibody-drug conjugate (ADC) Enhertu an option for previously untreated breast cancer for the ...

Once hailed as the future of immuno-oncology, it’s been a tough few months for any remaining fans of anti-TIGIT antibodies. | ...

In the 557-patient study, Enhertu reduced the risk of disease progression or death by 50%, whilst improving overall survival by 36% compared to chemotherapy – translating to an extra half year ...